
table of contents
A day in which regulatory restructuring, corporate trends, and clinical research are all progressing simultaneously.DEA rescheduling hearing,Federal regulations on hemp THC products are expected to be strengthened.,Expanding state-level medical cannabis programs and restricting sales in EuropeHowever, this could have widespread impacts on supply chains, tax systems, and investor sentiment.
概況
- In the United States,DEA hearing on transition to "Schedule III"In preparation for this, declarations of participation are pouring in from both supporters and opponents.
- At the federal level,New federal ban on hemp-derived THC productsIt is expected that Congress will not be able to rectify the situation this year. It has been suggested that the adjustments will be limited to minor changes to beverage and THC limits.Measurement methods including Delta 8/THCA,Total THC limit of 0.4 mg per containerThere are concerns that this will have a major impact on the market.
- In states and overseas,Georgia redesigns medical marijuana THC level regulations to milligram standard,Greece bans the sale of flowers nationwide.And so, the system design became concrete.
- In clinical practice and public health,MDMAVeterans trial of supportive therapy (approximately 80 people)AndEffectiveness of cannabinoid products in chronic painReports with quantitative data are appearing one after another. Risk studies regarding birth weight and academic impact are also being presented.
Regulation/Policy
DEA rescheduling hearing: both sides express interest in attending.
The US DEAStarts March 6thAt the public hearing, a more comprehensive approach to cannabis was discussed.Schedule IIIThe decision on whether to transition to this is scheduled to be reviewed. This comes shortly after a review of the classification of "state-approved medical marijuana" and FDA-approved marijuana products.NORMLThey stated that consumer voices should be reflected in the public hearing records and registered their participation. Joseph A. Bondy said,Schedule III is not the end point, but rather an intermediate correction." he argued. For investors and companies, the focus of the discussion is expected to be on tax aspects (such as the possibility of avoiding the 280E tax) and the reduction of barriers to research and development, but the conclusion remains undecided.Marijuana Moment) (NORML)
A new federal ban on hemp THC products is unlikely to be reversed by Congress.
Due to the legal amendments made last autumn,0.3% THC (dry weight)In calculating the standardデルタ9In addition toDelta-8/THCAAlso count, furtherConsumer products contain 0.4 mg of total THC per container.Restrict,Prohibition of synthetic and converted cannabinoidsIt is scheduled to come into effect in November.Marijuana Policy Project (MPP)He expressed the view that "it will be difficult for Congress to block it this year," and expressed concern about a significant market contraction, inventory write-downs, and increased costs for redesigning labels and formulations. While there may be "some minor adjustments" to beverages and THC limits, a fundamental overhaul seems unlikely.Marijuana Moment)
Georgia: Major revision of medical cannabis law to shift to quantity-based system (effective July 1, 2025)
Senate Bill 220 (Putting Georgia's Patients First Act)This has been established.THC 5% upper limitThe ban will be abolished, and patients' possession will beUp to 12,000mg THC (cumulative)The quantity model will now allow up to [a certain amount]. The target products include oils, tinctures, capsules, lozenges, etc.Drug-like packagingwithClear labeling of THC contentThis will be made mandatory.21 years old and aboveVaporizers are permitted (smoking is prohibited). Quantitative standardization clarifies inventory, logistics, and insurance reimbursement design.Transparency in supply planning and pricingPotentially contributes to...cannabisindustry.nl)
Greece: Bans retail sale of "flowers" regardless of THC/CBD content.
Under a new legal framework,The retail sale of flowers, whether dried or processed, is prohibited across the board.This applies to all distribution businesses.Licensed system at designated storesintroduction,More than 500m from elementary school/kindergartenLocation restrictions, etc., are also in place.CBDIt also affects the main regular market,Reformatting the product portfolioAnd costs are expected to be incurred due to the restructuring of inventory.cannabisindustry.nl)
A bill requiring the government to establish impulse control standards (drug effects while driving, etc.) has passed a House committee.
The House Transportation and Infrastructure Committee has spoken to federal authorities."Evidence-based imprisonment criteria"A bill calling for the proposal of the word "marijuana" is moving forward."intoxicating cannabinoids"This could also involve a replacement. This could affect transportation policy, employment safety standards, and insurance underwriting practices.Marijuana Moment)
| Regulatory Themes | Main figures and requirements | Anticipated economic impacts |
|---|---|---|
| DEA public hearing | Starting June 29th, we will begin considering Schedule III. | Potential impact on tax, R&D, and accounting/research expenses of listed companies. |
| Federal hemp regulations | Contains 0.3% D9/D8/THCA, with a total THC limit of 0.4mg per container. | Concerns about beverage/edible reconstitution costs and inventory write-downs. |
| GA Medical Cannabis | Maximum possession limit: 12,000mg THC; vaping permitted for those 21 years and older. | Improved demand forecasting, increased packaging and labeling costs. |
| Greek flower sales | The retail sale of flowers is prohibited across the board. | CBDShrinking flower market, cost of business model transformation |
Companies/Markets
Tilray Medical to participate in Cannabis Europa London 2026
Tilray BrandsTilray MedicalHe spoke on a panel at a London industry conference discussing policy, clinical practice, and regulation.Pilot Program,Policy design based on clinical dataThe theme is: Data-driven approval and reimbursement discussions could impact product mix and profitability (pharmaceuticals/quasi-pharmaceuticals).Business of Cannabis)
Industry conference: Discussions in Europe accelerate after the US transition to Schedule III.
Cannabis Europa 2026.This meeting is attracting attention as the first large-scale meeting since the US policy shift. Policymakers, investors, and patient groups will gather.Market restructuring issuesThis information is shared. The meeting serves as a platform for issuing signals regarding the cost of capital, valuation in the listed market, and insurance repayment prospects.Business of Cannabis)
How to View Marijuana Stocks for Investors: Learning and Selection are Key
The column for investors is,The sector is worth billions of dollars.It evolved into,The importance of identifying leading companies from both a market and management perspective.This was emphasized. While specific stocks and numerical evaluations were not provided, it urges a review of basic strategies in light of the regulatory shift (Schedule III, hemp regulations).Marijuana Stocks)
Supply and Product Trends: Emphasizing Compliance with New Strains
On the supply side,DEA-certified lab verification, legal logistics accounts, and fully compliant packaging.A move to put that front and center. In a phase of stricter regulations,COA and traceabilityThe development of these facilities will form the basis for securing sales channels and establishing a price premium.future4200)
| Company/Market Themes | Key Fact | Suggestion |
|---|---|---|
| Tilray Medical | "Evidence First" panel at European Conference | Focus on data-driven approval and repayment strategies |
| Essay for Investors | The sector is multi-billion in size. | Port reconfiguration in response to regulatory events |
| Supply Trends | DEA lab verification and compliance logistics clearly stated. | Sales permissibility and price formation under stricter regulations |
Public opinion and society
10 Facts About Marijuana in the United States (Pew Research)
Since 2012, the number of states where recreational use is legal has expanded.Nearly half of the states and DCIt allows both medical and personal use. It is still illegal under federal law,Relaxation of nationwide regulations on medical cannabisThe background to this progress is explained. Basic data on market size and voting behavior serves as a prerequisite for companies' store opening/advertising strategies and tax revenue forecasts.Pew Research)
Indiana: Judge suspended for 60 days without pay for marijuana use
This is an example where compliance with the law and professional ethics are strictly scrutinized, even within the legal profession.60-day unpaid suspensionIt is,Public sector governance and workplace policiesThis provides insights into the matter. It could also have repercussions for corporate compliance training and employment regulations.Cannabis Law Report)
Research/Clinical
Reports of significant improvement in chronic pain (fibromyalgia, rheumatoid arthritis, osteoarthritis)
For patients residing in California,12 weeks, 3 types of cannabinoid products (12.5mg each of THC/CBD,THCA 10mg + CBDa 10mg + CBG 5mg + CBC 3mg,CBD 10mg + CBDa 10mg) is administered in capsule form,Pain, mental health, cognition, and physical functionThis was self-reported and evaluated.Fibromyalgia 64 people, RA 25 people, OA 75 peopleParticipate,Significant improvementThis was shown. Differences in efficacy between formulations will directly impact future product design and pricing strategies.Marijuana Moment)
VA: Trial MDMA-assisted therapy for PTSD and alcohol use disorder in veterans
About 80 peopleHe is a veteran,MDMA+ PsychotherapywithPsychotherapy onlyCompare them. Following the Presidential Order,Access AccelerationWith this in mind, safety and effectiveness were verified. Supply constraints (e.g., difficulty in procuring ibogaine) were also pointed out.Supply chain for clinical trial raw materialsThat's the key. Once the treatment moves to the approval stage, the healthcare delivery system, reimbursement design, and treatment cost will create a new market.Marijuana Moment) (Marijuana Moment)
The link between usage patterns and abuse disorder (CUD): A nationwide representative survey (2022-2023)
adultn=25,549 (weighted N=58,850,309)In the NSDUH data,Smoking, vaporizing, oral use, dabbing, topical use, multimodalThe association between various patterns and CUD was examined using multiple variables. Stratification was performed by age, sex, and frequency. While the quantitative results are limited in the abstract,Product-specific differences in dependency riskThis is an important issue that could affect taxation, advertising, and age restrictions.PubMed)
Adolescence: Co-occurring CUD and other mental illnesses increase academic risk.
Adolescent CUD patients seeking treatmentN = 300so,Coexistence of internalization/externalization disordersThe group that has the odds of academic impairmentOR = 3.73 (95% CI: 1.06-13.12)The odds of repeating a year or dropping out areOR = 2.05 (95% CI: 1.10-3.84)And it rose. This suggests the need to establish a collaborative system between schools, families, and medical institutions.PubMed)
Perinatal period: Fetal exposure and birth weight
US multicenter longitudinal cohortHBCDcomes660 mother-child pairsso,Cannabis exposure during fetal development The-272.2g (95%CI -444.6 to -99.8)It is associated with low birth weight.Opioid exposureThen.-295.4gA decline in [the relevant information]. This relates to the practical aspects of perinatal guidance, labeling, and age verification.PubMed)
Basic research: CBDA and cell motility (breast cancer cells)
CBDA ≈ 25 μMwith accommodation.ROCK inhibitionSimilar effects were suggested,Disorders of tail contractionMorphological changes were observed. While this contributes to the search for potential drug candidates, further verification is needed before clinical application.PubMed)
Academic perspective (statistics): "Schedule III," "THCA," and "Inspiration Criteria" are technical terms.
Schedule III = A category where the potential for abuse is considered moderate or less, and medical use is permitted. This affects tax and research licensing.
THCA is a precursor that converts to THC when heated. Regulations may count it as part of the total THC content, which directly impacts formulation and labeling.
- Impairment criteria = Rules that define conditions that impede driving or work using measurable indicators.
Statistics can help determine which policies or product designs are advantageous by comparing the effects of these terms and the impact of regulations using "numerical" data.
Product technology
SOP (Developer Post) for Instant-Acting THC Edibles
Phospholipids + sugars\Fast-acting cannabinoidsA prototype SOP for the formulation was shared within the community.Isopropanol used → No residue in the final product.It is clearly stated that the rapid absorption format isDosage reproducibilitywithConsistency of perceptionThis is key to market evaluation. Regulatory compliance (residual solvents, food safety) and COA (Certificate of Authenticity) preparation are conditions for commercialization.future4200)
Today's highlights
- Federal hemp regulationsThe expected implementation date in November is,0.4mg/container, D8/THCA included.This could lead to increased redesign costs and inventory risks for beverages and edibles. Investors are re-evaluating sensitivity across the value chain.
- DEA public hearingThe Schedule III discussions are an intermediate event that could change the assumptions of tax, research, and insurance.NORMLThe participation of consumer representatives such asVoices from the demand sideThis is important for documenting policy.
- Georgia's 12,000mg THC possession limit,Flower sales banned in GreeceSuch,Milligram standardization / Regulation by formThis dictates pricing, form factor, and distribution channel structure. Companies need to quickly adapt their packaging, labeling, and formulation.
Collection List
- 10 facts about Americans and marijuana — Pew Research — https://www.pewresearch.org/short-reads/2026/05/26/facts-about-marijuana/
- Fresh Strains Dropping — Future4200 — https://future4200.com/t/fresh-strains-dropping/243495
- 3 Marijuana Stocks For Better Investing In 2026 — Marijuana Stocks — https://marijuanastocks.com/3-marijuana-stocks-for-better-investing-in-2026/
- Marijuana Legalization Supporters And Opponents File Notices To Participate In DEA Hearing On Rescheduling Next Month — Marijuana Moment — https://www.marijuanamoment.net/marijuana-legalization-supporters-and-opponents-file-notices-to-participate-in-dea-hearing-on-rescheduling-next-month/
- NORML Seeks Seat at DEA Marijuana Rescheduling Hearing, Says Consumers Must Be Represented — NORML — https://norml.org/blog/2026/05/26/norml-seeks-seat-at-dea-marijuana-rescheduling-hearing-says-consumers-must-be-represented/
- The Final Boss of Edible Recipes! — Future4200 — https://future4200.com/t/the-final-boss-of-edible-recipes/243492
- VA Launches New Study On MDMA To Treat Veterans With PTSD And Alcohol Use Disorder — Marijuana Moment — https://www.marijuanamoment.net/va-launches-new-study-on-mdma-to-treat-veterans-with-ptsd-and-alcohol-use-disorder/
- Cannabis Provides 'Significant Improvements' In Pain For Fibromyalgia, Rheumatoid Arthritis And Osteoarthritis Patients, Study Shows — Marijuana Moment — https://www.marijuanamoment.net/cannabis-provides-significant-improvements-in-pain-for-fibromyalgia-rheumatoid-arthritis-and-osteoarthritis-patients-study-shows/
- Amerikaanse staat Georgia breidt medicinale cannabis toegang uit met nieuwe wet — cannabisindustrie.nl — https://cannabisindustrie.nl/georgia-uitbreiding-medicinale-cannabis-toegang/
- Congress Is Unlikely To Prevent A New Federal Ban On Hemp THC Products This Year, Top Marijuana Reform Group Says — Marijuana Moment — https://www.marijuanamoment.net/congress-is-unlikely-to-prevent-a-new-federal-ban-on-hemp-thc-products-this-year-top-marijuana-reform-group-says/
- Problems Finding Ibogaine To Be Used In Research Could Slow Trump Administration's Psychedelic Therapy Push For Veterans, VA Secretary Says — Marijuana Moment — https://www.marijuanamoment.net/problems-finding-ibogaine-to-be-used-in-research-could-slow-trump-administrations-psychedelic-therapy-push-for-veterans-va-secretary-says/
- Cannabis Europa London 2026 – Key Insights, Day 1 (LIVE) — Business of Cannabis — https://businessofcannabis.com/cannabis-europa-london-2026-key-insights-day-1-live/
- VA cannabis docs reveal Schedule III impact for veterans (Newsletter: May 26, 2026) — Marijuana Moment — https://www.marijuanamoment.net/va-cannabis-docs-reveal-schedule-iii-impact-for-veterans-newsletter-may-26-2026/
- Indiana: Lawrence Co. judge suspended over cannabis use — Cannabis Law Report — https://cannabislaw.report/indiana-lawrence-co-judge-suspended-over-cannabis-use/
- Griekenland verbiedt verkoop cannabisbloemen, ongeacht THC- of CBD-gehalte — cannabisindustrie.nl — https://cannabisindustrie.nl/griekenland-verbiedt-verkoop-cannabisbloemen/
- Tilray Medical Brings Global Medical Cannabis Expertise to Cannabis Europa London 2026 — Business of Cannabis — https://businessofcannabis.com/tilray-medical-europe-named-silver-partner-at-cannabis-europa-london-2026/
- Associations between modes of cannabis use and cannabis use disorder: Evidence from the 2022 to 2023 United States National Survey on Drug Use and Health — PubMed — https://pubmed.ncbi.nlm.nih.gov/42186749/
- Cannabidiolic acid causes a defect in tail retraction of migrating MDA-MB-231 cells: Possible involvements of Rho-associated protein kinases (ROCKs) inhibition and accumulation of vinculin at the rear of migrating cells — PubMed — https://pubmed.ncbi.nlm.nih.gov/42186359/
- Correction: Visualizing glutathione levels in adipose tissue: a CBD aryl ether thiolysis-activated ESIPT probe for obesity research — PubMed — https://pubmed.ncbi.nlm.nih.gov/42186314/
- Adolescent with cannabis use disorder and other mental health disorders: does dual disorder worsen school impairment? — PubMed — https://pubmed.ncbi.nlm.nih.gov/42186072/
- Prenatal Substance Exposure and Birth Weight: Findings From the HEALthy Brain and Child Development Study — PubMed — https://pubmed.ncbi.nlm.nih.gov/42184970/

![Mail-order product: MDMA × MM Analog [For Research Use]](https://www.thch-vape.shop/html/user_data/assets/img/products/213_250x250.webp)


